REPOCEUTICALS A/S: Financial statements 2016
CVR: 36494433
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
REPOCEUTICALS A/S (CVR 36494433) has filed annual accounts for 2016. In 2016, the company reported a net result of DKK -211,162 compared with DKK -34,034 the year before. Equity in the 2016 report amounted to DKK 104,803. The solvency ratio was 12.3%.
- Profit/Loss
- DKK -211,162
- Equity
- DKK 104,803
- Total Assets
- DKK 852,659
Official annual report
Find more companies like REPOCEUTICALS A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2016
As of August 17, 2016, CLINICURO ApS is registered as an owner of REPOCEUTICALS A/S with an ownership share of 5%.
REPOCEUTICALS A/S has published its annual report for 2015. The net result was DKK -34,034.
As of June 20, 2016, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of REPOCEUTICALS A/S.
As of April 20, 2016, Torsten Bjørn is registered as director of REPOCEUTICALS A/S.
As of April 20, 2016, Henrik Lasse Lindblad has stepped down as director of REPOCEUTICALS A/S.
About REPOCEUTICALS A/S
REPOCEUTICALS A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2015. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named REPOCEUTICALS ApS. The management consists of Torsten Bjørn. The board consists of Henrik Bulskov (chair), Charlotte Pahl and Christian Vinding Thomsen. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and DMZ HOLDING ApS. The company has 2 employees (2026). In 2025, the company reported revenue of DKK 88,000,000 and a net result of DKK -6,228,938,000 compared with DKK -6,274,548 the year before. Equity in the 2025 report amounted to DKK 6,245,088,000.